Effects of varenicline on smoking cue-triggered neural and craving responses

Archives of General Psychiatry

Volumn 68, Issue 5, 2011, Pages 516-526

  Franklin, Teresa ^a   Wang, Ze ^a   Suh, Jesse J ^a,b   Hazan, Rebecca ^a   Cruz, Jeffrey ^a   Li, Yin ^a   Goldman, Marina ^a   Detre, John A ^a   O'Brien, Charles P ^a,b   Childress, Anna Rose ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VARENICLINE;

ADULT; ARTICLE; ASSOCIATION; BRAIN PERFUSION; CLINICAL ARTICLE; CORPUS STRIATUM; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; ORBITAL CORTEX; POSTERIOR CINGULATE; RANDOMIZED CONTROLLED TRIAL; SMOKING; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ADULT; BASAL GANGLIA; BENZAZEPINES; CONDITIONING (PSYCHOLOGY); CUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FRONTAL LOBE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MOTIVATION; NICOTINIC AGONISTS; QUINOXALINES; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 79955642716     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2010.190     Document Type: Article

References (58)

1. Perkins KA. Smoking cessation in women: special considerations. CNS Drugs. 2001;15(5):391-411. (Pubitemid 32487995)
2. Sinha R, Li CS. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev. 2007;26 (1):25-31.
3. Dagher A, Tannenbaum B, Hayashi T, Pruessner JC, McBride D. An acute psychosocial stress enhances the neural response to smoking cues. Brain Res. 2009; 1293:40-48.
4. Franklin TR, Ehrman R, Lynch KG, Harper D, Sciortino N, O'Brien CP, Childress AR. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt). 2008;17(2):287-292. (Pubitemid 351631249)
5. Perkins KA, Marcus MD, Levine MD, D'Amico D, Miller A, Broge M, Ashcom J, Shiffman S. Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. J Consult Clin Psychol. 2001;69(4):604-613. (Pubitemid 32803849)
6. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, Sved AF. Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav. 2001;70(4):515-530. (Pubitemid 34131646)
7. Baker TB, Morse E, Sherman JE. The motivation to use drugs: a psychobiological analysis of urges. Nebr Symp Motiv. 1986;34:257-323.
8. Killen JD, Fortmann SP. Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol. 1997;5(2):137-142. (Pubitemid 27239815)
9. Rose JE. Nicotine addiction and treatment. Annu Rev Med. 1996;47:493-507. (Pubitemid 26138907)
10. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9(3):315-327. (Pubitemid 46404264)
11. Drummond DC. What does cue-reactivity have to offer clinical research? Addiction. 2000;95(suppl 2):S129-S144.
12. Janes AC, Pizzagalli DA, Richardt S, deB Frederick B, Chuzi S, Pachas G, Culhane MA, Holmes AJ, Fava M, Evins AE, Kaufman MJ. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry. 2010;67(8):722-729.
13. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57-71.
14. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y,Mansbach RS, Chambers LK, Rovetti CC, Schulz DW, Tingley FD III, O'Neill BT. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48(10):3474-3477. (Pubitemid 40664098)
15. Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci. 2007;28(7):316-325. (Pubitemid 47016686)
16. Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006;6:300.
17. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2008;(3):CD006103.
18. Brody AL, Mandelkern MA, London ED, Childress AR, Lee GS, Bota RG, Ho ML, Saxena S, Baxter LR Jr, Madsen D, Jarvik ME. Brain metabolic changes during cigarette craving. Arch Gen Psychiatry. 2002;59(12):1162-1172. (Pubitemid 35424027)
19. Childress AR, Ehrman RN, Wang Z, Li Y, Sciortino N, Hakun J, Jens W, Suh J, Listerud J, Marquez K, Franklin T, Langleben D, Detre J, O'Brien CP. Prelude to passion: limbic activation by "unseen" drug and sexual cues. PLoS ONE. 2008; 3(1):e1506.
20. McClernon FJ, Kozink RV, Rose JE. Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacology. 2008;33(9):2148-2157. (Pubitemid 351992088)
21. Langleben DD, Ruparel K, Elman I, Busch-Winokur S, Pratiwadi R, Loughead J, O'Brien CP, Childress AR. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry. 2008;165(3):390-394. (Pubitemid 351704496)
22. Franklin TR, Lohoff FW, Wang Z, Sciortino N, Harper D, Li Y, Jens W, Cruz J, Kampman K, Ehrman R, Berrettini W, Detre JA, O'Brien CP, Childress AR. DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology. 2009;34(3):717-728.
23. Franklin TR, Wang Z, Wang J, Sciortino N, Harper D, Li Y, Ehrman R, Kampman K, O'Brien CP, Detre JA, Childress AR. Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology. 2007;32(11):2301-2309. (Pubitemid 47587682)
24. Franklin TR, Wang Z, Li Y, Suh J, Goldman M, Lohoff F, Cruz J, Hazan, Jens W, Detre JA, Berretini W, O'Brien CP, Childress AR. Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. Addict Biol. In press.
25. Franklin TR, Druhan TP. Involvement of the nucleus accumbens and medial prefrontal cortex in the expression of conditioned hyperactivity to a cocaineassociated environment in rats. Neuropsychopharmacology. 2000;23(6):633-644.
26. Corrigall WA, Franklin KB, Coen KM, Clarke PB. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl). 1992;107(2-3):285-289.
27. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol. 2000;393(1-3):295-314. (Pubitemid 30193428)
28. Kringelbach ML. The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci. 2005;6(9):691-702. (Pubitemid 43160318)
29. Rolls ET. The functions of the orbitofrontal cortex. Brain Cogn. 2004;55(1): 11-29. (Pubitemid 38591427)
30. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev. 2002;26(3):321-352. (Pubitemid 34555410)
31. Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S, Cadoni C, Carboni E. Drug addiction as a disorder of associative learning: role of nucleus accumbens shell/extended amygdala dopamine. Ann N Y Acad Sci. 1999;877:461-485. (Pubitemid 29351873)
32. Small DM, Zatorre RJ, Dagher A, Evans AC, Jones-Gotman M. Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain. 2001; 124(pt 9):1720-1733. (Pubitemid 32845434)
33. Elliott R, Dolan RJ, Frith CD. Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cereb Cortex. 2000;10(3):308-317. (Pubitemid 30159297)
34. Wang Z, Faith M, Patterson F, Tang K, Kerrin K, Wileyto EP, Detre JA, Lerman C. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci. 2007;27(51):14035-14040. (Pubitemid 351377866)
35. Stein EA, Pankiewicz J, Harsch HH, Cho JK, Fuller SA, Hoffmann RG, Hawkins M, Rao SM, Bandettini PA, Bloom AS. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry. 1998;155 (8):1009-1015. (Pubitemid 28357723)
36. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab. 1996; 16(6):1236-1249. (Pubitemid 26365376)
37. Hermes M, Hagemann D, Britz P, Lieser S, Rock J, Naumann E, Walter C. Reproducibility of continuous arterial spin labeling perfusion MRI after 7 weeks. MAGMA. 2007;20(2):103-115. (Pubitemid 46684543)
38. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12(2):159-182. (Pubitemid 19191503)
39. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-57.
40. Weschler D. Wechsler Abbreviated Scale of Intelligence Manual. San Antonio, TX: Harcourt Brace & Co; 1999.
41. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29(7):1422-1431. (Pubitemid 27272432)
42. Wilson SJ, Sayette MA, Fiez JA, Brough E. Carry-over effects of smoking cue exposure on working memory performance. Nicotine Tob Res. 2007;9(5):613-619. (Pubitemid 46672440)
43. Sharma D,Money S. Carryover effects to addiction-associated stimuli in a group of marijuana and cocaine users. J Psychopharmacol. 2010;24(9):1309-1316.
44. Waters AJ, Sayette MA, Franken IH, Schwartz JE. Generalizability of carry-over effects in the emotional Stroop task. Behav Res Ther. 2005;43(6):715-732. (Pubitemid 40693697)
45. Shiffman SM, Jarvik ME. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology (Berl). 1976;50(1):35-39.
46. Duvernoy HM. The Human Brain: Surface, Three-Dimensional Sectional Anatomy with Magnetic Resonance Imaging and Blood Supply. 2nd ed. New York, NY: Springer-Verlag Wien; 1999.
47. Mai JK, Voss T, Paxinos G. Atlas of the Human Brain. 3rd ed. New York, NY: Elsevier Academic Press; 2008.
48. Naqvi NH, Rudrauf D, Damasio H, Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science. 2007;315(5811):531-534. (Pubitemid 46175760)
49. Elliott R, Agnew Z, Deakin JF. Hedonic and informational functions of the human orbitofrontal cortex. Cereb Cortex. 2010;20(1):198-204.
50. McClernon FJ, Hiott FB, Huettel SA, Rose JE. Abstinence-induced changes in selfreport craving correlate with event-related FMRI responses to smoking cues. Neuropsychopharmacology. 2005;30(10):1940-1947. (Pubitemid 41486419)
51. David SP, Munafò MR, Johansen-Berg H, Smith SM, Rogers RD, Matthews PM, Walton RT. Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry. 2005;58(6):488-494. (Pubitemid 41393611)
52. Due DL, Huettel SA, Hall WG, Rubin DC. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry. 2002;159(6):954-960. (Pubitemid 34586940)
53. Kirsch P, Reuter M, Mier D, Lonsdorf T, Stark R, Gallhofer B, Vaitl D, Hennig J. Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett. 2006;405(3):196-201. (Pubitemid 44189725)
54. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98(12): 6917-6922. (Pubitemid 32538317)
55. Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR. The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage. 2002;17(1):317-323.
56. Hariri AR, Weinberger DR. Imaging genomics. Br Med Bull. 2003;65:259-270. (Pubitemid 36406471)
57. Yoshimasu K, Kiyohara C. Genetic influences on smoking behavior and nicotine dependence: a review. J Epidemiol. 2003;13(4):183-192. (Pubitemid 44130741)
58. Wilens TE, Vitulano M, Upadhyaya H, Adamson J, Sawtelle R, Utzinger L, Biederman J. Cigarette smoking associated with attention deficit hyperactivity disorder. J Pediatr. 2008;153(3):414-419.